Maximilian Gerner
Overview
Explore the profile of Maximilian Gerner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
9
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Beck M, Kuwert T, Atzinger A, Gerner M, Hartmann A, Saake M, et al.
Visc Med
. 2025 Feb;
41(1):1-13.
PMID: 39927190
Introduction: The development of an intestinal stricture in patients with Crohn's disease represents an important and frequent complication, reflecting the progressive nature of the disease. Depending on the inflammatory and...
2.
Wobbe B, Gerner M, Kohne C
J Pain Palliat Care Pharmacother
. 2024 Dec;
:1-18.
PMID: 39699576
Naldemedine is a peripheral acting µ-opioid receptor antagonist approved by the Food and Drug Administration to treat opioid-induced constipation. Concerns about side effects like opioid withdrawal prevent its widespread use,...
3.
Wobbe B, Gerner M, Kohne C
BMJ Support Palliat Care
. 2022 Dec;
13(e3):e578-e584.
PMID: 36517204
Objective: Opioid-induced constipation (OIC) is a frequent adverse event among patients receiving chronic pain therapy that is requiring opioids. Naldemedine was approved by the Food and Drug Administration to treat...
4.
Yalcin Mutlu M, Taubmann J, Wacker J, Tascilar K, Fagni F, Gerner M, et al.
Front Med (Lausanne)
. 2022 Aug;
9:934169.
PMID: 35991632
Patients with immune-mediated diseases (IMID) such as systemic sclerosis (SSc), who are treated with B cell depleting treatments, are at risk for developing severe COVID-19 due to inadequate humoral immune...
5.
Gerner M, Vuillerme N, Aubourg T, Messner E, Terhorst Y, Hormann V, et al.
JMIR Mhealth Uhealth
. 2022 May;
10(5):e31102.
PMID: 35503246
Background: Patients suffering from inflammatory bowel disease (IBD) frequently need long-term medical treatment. Mobile apps promise to complement and improve IBD management, but so far there has been no scientific...